Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma

Cancer

Volumn 107, Issue 9, 2006, Pages 2282-2290

  Brown, Elizabeth E ^a,b,i   Whitby, Denise ^c   Vitale, Francesco ^d   Marshall, Vickie ^c   Mbisa, Georgina ^c   Gamache, Christine ^c   Lauria, Carmela ^e   Alberg, Anthony J ^b   Serraino, Diego ^f   Cordiali Fei, Paola ^g   Messina, Angelo ^h   Goedert, James J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c SAIC FREDERICK INC   (United States)

^d UNIVERSITY OF PALERMO   (Italy)

^e Lega Italiana per la Lotta Contro i Tumori Sez Ragusa   (Italy)

^f CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^g SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^h UNIVERSITY OF CATANIA   (Italy)

ⁱ UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Biomarker; Human herpesvirus 8; Immunity; Kaposi sarcoma; Kaposi sarcoma associated herpesvirus

Indexed keywords

ANTIGEN; BETA 2 MICROGLOBULIN; CD4 ANTIGEN; CD8 ANTIGEN; K8.1 ANTIGEN; LATENCY ASSOCIATED NUCLEAR ANTIGEN; LATENCY ASSOCIATED NUCLEAR ANTIGEN ANTIBODY; NEOPTERIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY TITER; ANTIGEN DETECTION; ARTICLE; BLOOD CELL COUNT; CANCER RISK; CD4 LYMPHOCYTE COUNT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNITY; IMMUNOFLUORESCENCE; KAPOSI SARCOMA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MULTIVARIATE ANALYSIS; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RISK FACTOR; STRUCTURAL GENE; VIRUS DETECTION; VIRUS LOAD;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; ITALY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; SARCOMA, KAPOSI;

EID: 33750496906     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22236     Document Type: Article

References (39)

1. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994;266:1865-1869.
2. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med. 1995;332:1181-1185.
3. Moore PS, Kingsley LA, Holmberg SD, et al. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. Aids. 1996;10;175-180.
4. Whitby D, Luppi M, Barozzi P, Boshoff C, Weiss RA, Torelli G. Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst. 1998;90:395-397.
5. Engels EA, Biggar RJ, Marshall VA, et al. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma. Aids. 2003;17:1847-1851.
6. Touloumi G, Hatzakis A, Potouridou I, et al. The role of immunosuppression and immune-activation in classic Kaposi's sarcoma. Int J Cancer. 1999;82:817-821.
7. Stratigos AJ, Malanos D, Touloumi G, et al. Association of clinical progression in classic Kaposi's sarcoma with reduction of peripheral B lymphocytes and partial increase in serum immune activation markers. Arch Dermatol. 2005;141:1421-1426.
8. Barillari G, Buonaguro L, Fiorelli V, et al. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis. J Immunol. 1992;149:3727-3734.
9. Kestens L, Melbye M, Biggar RJ, et al. Endemic African Kaposi's sarcoma is not associated with immunodeficiency. Int J Cancer. 1985;36:49-54.
10. Santelli G, Melillo G, Marfella A, et al. Urinary neopterin and immunological features in patients with Kaposi's sarcoma. Eur J Cancer Clin Oncol. 1988;24:1391-1396.
11. Goedert JJ, Vitale F, Lauria C, et al. Risk factors for classical Kaposi's sarcoma. J Natl Cancer Inst. 2002;94:1712-1718.
12. Whitby D, Howard MR, Tenant-Flowers M, et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet. 1995;346:799-802.
13. Yuan CC, Miley W, Waters D. A quantification of human cells using an ERV-3 real time PCR assay. J Virol Methods. 2001;91:109-117.
14. de Sanjose S, Marshall V, Sola J, et al. Prevalence of Kaposi's sarcoma-associated herpesvirus infection in sex workers and women from the general population in Spain. Int J Cancer. 2002;98:155-158.
15. Luppi M, Barozzi P, Maiorana A, et al. Frequency and distribution of herpesvirus-like DNA sequences (KSHV) in different stages of classic Kaposi's sarcoma and in normal tissues from an Italian population. Int J Cancer. 1996;66:427-431.
16. Cattani P, Capuano M, Lesnoni La Parola I, et al. Human herpesvirus 8 in Italian HIV-seronegative patients with Kaposi sarcoma. Arch Dermatol. 1998;134:695-699.
17. Cannon MJ, Dollard SC, Black JB, et al. Risk factors for Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus. Aids. 2003;17:215-222.
18. Staskus KA, Zhong W, Gebhard K, et al. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol. 1997;71:715-719.
19. Beckstead JH, Wood GS, Fletcher V. Evidence for the origin of Kaposi's sarcoma from lymphatic endothelium. Am J Pathol. 1985;119:294-300.
20. Miles SA, Rezai AR, Salazar-Gonzalez JF, et al. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc Natl Acad Sci U S A. 1990;87:4068-4072.
21. Yang J, Hagan MK, Offermann MK. Induction of IL-6 gene expression in Kaposi's sarcoma cells. J Immunol. 1994;152:943-955.
22. Sturzl M, Brandstetter H, Zietz C, et al. Identification of interleukin-1 and platelet-derived growth factor-B as major mitogens for the spindle cells of Kaposi's sarcoma: a combined in vitro and in vivo analysis. Oncogene. 1995;10:2007-2016.
23. Xerri L, Hassoun J, Planche J, et al. Fibroblast growth factor gene expression in AIDS-Kaposi's sarcoma detected by in situ hybridization. Am J Pathol. 1991;138:9-15.
24. Cornali E, Zietz C, Benelli R, et al. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma. Am J Pathol. 1996;149:1851-1869.
25. Cesarman E, Mesri EA, Gershengorn MC. Viral G protein-coupled receptor and Kaposi's sarcoma: a model of paracrine neoplasia? J Exp Med. 2000;191:417-422.
26. Ensoli B, Sirianni MC. Kaposi's sarcoma pathogenesis: a link between immunology and tumor biology. Crit Rev Oncog. 1998;9:107-124.
27. Myers BD, Kessler E, Levi J, Pick A, Rosenfeld JB, Tikvah P. Kaposi's sarcoma in kidney transplant recipients. Arch Intern Med. 1974;133:307-311.
28. Akhtar M, Bunuan H, Ali MA, Godwin JT. Kaposi's sarcoma in renal transplant recipients. Ultrastructural and immunoperoxidase study of four cases. Cancer. 1984;53:258-266.
29. Real FX, Krown SE, Koziner B. Steroid-related development of Kaposi's sarcoma in a homosexual man with Burkitt's lymphoma. Am J Med. 1986;80:119-122.
30. Brooks JJ. Kaposi's sarcoma: a reversible hyperplasia. Lancet. 1986;2:1309-1311.
31. Janier M, Vignon MD, Cottentot F. Spontaneously healing Kaposi's sarcoma in AIDS. N Engl J Med. 1985;312:1638-1639.
32. Real FX, Krown SE. Spontaneous regression of Kaposi's sarcoma in patients with AIDS. N Engl J Med. 1985;313:1659.
33. Marinig C, Fiorini G, Boneschi V, Melotti E, Brambilla L. Immunologic and immunogenetic features of primary Kaposi's sarcoma. Cancer. 1985;55:1899-1901.
34. Kaloterakis A, Stratigos J, Trichopoulos D, Karabinis A, Elemenoglou S. Mediterranean Kaposi's sarcoma: preliminary communication about 131 cases. Bull Soc Pathol Exot Filiales. 1984;77(4 Pt 2):570-571.
35. Monini P, Colombini S, Sturzl M, et al. Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. Blood. 1999;93:4044-4058.
36. Davis DA, Rinderknecht AS, Zoeteweij JP, et al. Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus. Blood. 2001;97:3244-3250.
37. Brown EE, Fallin MD, Goedert JJ, et al. A common genetic variant in FCGR3A-V158F and risk of Kaposi sarcoma herpesvirus infection and classic Kaposi sarcoma. Cancer Epidemiol Biomarkers Prev. 2005;14:633-637.
38. Brown EE, Fallin MD, Ruczinski I, et al. Associations of classic Kaposi sarcoma with common variants in genes that modulate host immunity. Cancer Epidemiol Biomarkers Prev. 2006;15:926-934.
39. Brown EE, Fallin MD, Goedert JJ, et al. Host immunogenetics and control of human herpesvirus-8 infection. J Infect Dis. 2006;193:1054-1062.